MCF Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Sell |
1,287
-2,113
| -62% | -$857K | 0.03% | 147 |
|
|
2025
Q1 | $1.69M | Sell |
3,400
-115
| -3% | -$57.3K | 0.12% | 58 |
|
|
2024
Q4 | $1.83M | Buy |
3,515
+560
| +19% | +$291K | 0.13% | 57 |
|
|
2024
Q3 | $1.83M | Buy |
2,955
+37
| +1% | +$22.9K | 0.13% | 57 |
|
|
2024
Q2 | $1.61M | Sell |
2,918
-58
| -2% | -$32.1K | 0.12% | 58 |
|
|
2024
Q1 | $1.73M | Sell |
2,976
-17
| -0.6% | -$9.89K | 0.13% | 55 |
|
|
2023
Q4 | $1.59M | Buy |
2,993
+1,176
| +65% | +$625K | 0.13% | 55 |
|
|
2023
Q3 | $920K | Buy |
1,817
+679
| +60% | +$344K | 0.08% | 81 |
|
|
2023
Q2 | $594K | Sell |
1,138
-1,310
| -54% | -$684K | 0.05% | 109 |
|
|
2023
Q1 | $1.41M | Sell |
2,448
-9
| -0.4% | -$5.19K | 0.13% | 51 |
|
|
2022
Q4 | $1.35M | Buy |
2,457
+541
| +28% | +$298K | 0.14% | 50 |
|
|
2022
Q3 | $972K | Buy |
1,916
+811
| +73% | +$411K | 0.11% | 67 |
|
|
2022
Q2 | $601K | Sell |
1,105
-43
| -4% | -$23.4K | 0.06% | 81 |
|
|
2022
Q1 | $678K | Buy |
+1,148
| New | +$678K | 0.06% | 92 |
|
|
2021
Q4 | – | Sell |
-750
| Closed | -$429K | – | 620 |
|
|
2021
Q3 | $429K | Buy |
750
+257
| +52% | +$147K | 0.04% | 114 |
|
|
2021
Q2 | $249K | Buy |
493
+154
| +45% | +$77.8K | 0.03% | 153 |
|
|
2021
Q1 | $155K | Buy |
+339
| New | +$155K | 0.02% | 185 |
|
|
2015
Q2 | – | Sell |
-83
| Closed | -$11K | – | 450 |
|
|
2015
Q1 | $11K | Hold |
83
| – | – | ﹤0.01% | 319 |
|
|
2014
Q4 | $10K | Hold |
83
| – | – | ﹤0.01% | 310 |
|
|
2014
Q3 | $10K | Buy |
+83
| New | +$10K | ﹤0.01% | 320 |
|